Illumina, Inc. (NasdaqGS:ILMN) acquired Fluent BioSciences Inc. on July 9, 2024. The acquisition closed on July 9, 2024, and has been funded with cash on hand. The Fluent team will join Illumina, and PIPseq V will be integrated into Illumina's product portfolio.

Illumina, Inc. (NasdaqGS:ILMN) completed the acquisition of Fluent BioSciences Inc. on July 9, 2024.